Edgewise Therapeutics Stock Gains After Corporate Update
Edgewise Therapeutics shares rose 3% on January 13 after outlining 2026 priorities, including key drug trial milestones. Analysts maintain positive ratings.
Structure Therapeutics Stock Surges on Positive Obesity Pill Data
Structure Therapeutics shares have risen over 130% in three months after reporting positive clinical trial results for its oral obesity pill, with analysts maintaining bullish ratings.
Alphatec Holdings Reports Strong Preliminary 2025 Results and 2026 Outlook
Alphatec Holdings announced preliminary 2025 financial results on January 12, showing 25% revenue growth and providing a 2026 outlook. The company also entered a strategic agreement with Theradaptive for exclusive U.S. distribution rights to OsteoAdapt.
AMD Stock Rises on TSMC Earnings and Wells Fargo Upgrade
AMD stock surged 6% after TSMC reported strong Q4 2025 earnings. Wells Fargo analyst Aaron Rakers upgraded AMD to 'top pick,' forecasting 55% growth driven by CPU leadership and AI positioning.
Terns Pharmaceuticals Receives Analyst Backing After Positive Drug Data
Terns Pharmaceuticals saw analyst support with Truist and Mizuho reiterating buy ratings after Phase 1 data for its CML drug TERN-701 showed a 64% response rate, with shares up over 300% in three months.
Uber Receives Mixed Analyst Ratings Amid Robotaxi Service Milestone
Uber Technologies received analyst rating updates with varied price targets, while announcing robotaxi service progress including production vehicles and autonomous testing.
AMD Launches New AI Embedded Processors and Expands HPE Partnership
AMD introduced Ryzen AI Embedded processors on Jan 5 for edge AI applications and expanded its collaboration with HPE on Jan 2 for scalable AI infrastructure.
Eli Lilly Reports Positive Trial Results and Announces Ventyx Acquisition
Eli Lilly's Taltz and Zepbound show superior efficacy in a Phase 3b trial for psoriatic arthritis and obesity. The company also agreed to acquire Ventyx Biosciences for about $1.2 billion.
ServiceNow Receives Revised Price Targets Ahead of Earnings
Stifel and Wells Fargo adjusted ServiceNow's price targets in early January, maintaining positive ratings. The updates followed the company's announcement of its Q4 and full-year earnings release date.
Arista Networks Receives Analyst Upgrades and Target Adjustments
Piper Sandler upgraded Arista Networks to Overweight with a $159 price target on January 5, citing 2026 as a 'Year of Refresh.' Melius Research maintained a Buy rating with a $200 target, while Morgan Stanley cut its target to $159 on December 17 but kept an Overweight rating.
Palantir Receives Mixed Analyst Ratings Amid AI Growth
Truist initiated coverage of Palantir with a Buy rating and $223 target, citing AI-driven growth, while RBC Capital reiterated a Sell rating with a $50 target.
Cantor Fitzgerald Raises KLA Price Target to $1,750
Cantor Fitzgerald raised KLA Corporation's price target to $1,750 on January 8, maintaining an Overweight rating. The firm cited high conviction and anticipated growth in wafer fabrication equipment through 2028.
Berkshire Hathaway Holds Domino's Pizza Shares as Chain Reports Growth
Berkshire Hathaway holds nearly 3 million Domino's Pizza shares. The pizza chain reported sales growth and expansion, with its stock trading at an attractive valuation.
Analysts Issue Mixed Ratings for AT&T as Airline Wi-Fi Partnership Launches
AT&T received analyst rating updates in January, including a Buy from Bernstein and downgrades from KeyBanc and Arete. The company also announced a partnership with American Airlines for free in-flight Wi-Fi.
Fortinet Receives Mixed Analyst Ratings Ahead of Earnings Release
Fortinet received updated ratings from RBC Capital and Piper Sandler on January 5, with price targets adjusted. The company will announce its fiscal Q4 and full-year 2025 results on February 5.